This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wilson, J. Articles by Scheer, A. Search for Related Content PubMed PubMed Citation Articles by Wilson, J. Articles by Scheer, A. Social Bookmarking                   What's this?

A Homogeneous 384-Well High-Throughput Binding Assay for a TNF Receptor Using Alphascreen Technology

Serono Pharmaceutical Research Institute, 14 Ch. des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland

Claudia Pena Rossi

Serono International S.A., 15 Ch. des Mines, 1202 Geneva, Switzerland

Susanna Carboni

Serono Pharmaceutical Research Institute, 14 Ch. des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland

Christèle Fremaux

Serono Pharmaceutical Research Institute, 14 Ch. des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland

Dominique Perrin

Serono Pharmaceutical Research Institute, 14 Ch. des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland

Claudio Soto

Serono International S.A., 15 Ch. des Mines, 1202 Geneva, Switzerland

Marie Kosco-Vilbois

NovImmune SA, 64 Ave de la Roseraie, 1211 Geneva 4, Switzerland

Alexander Scheer

Serono Pharmaceutical Research Institute, 14 Ch. des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland, alexander.scheer{at}serono.com

To take advantage of the growing knowledge of cellular signaling pathways, modern-day drug discovery faces an increasing challenge to develop assays to screen for compounds that modulate protein-protein interactions. One bottleneck in achieving this goal is a lack of suitable and robust assay technologies amenable to a high-throughput format. In this report, we describe how we utilized Alphascreen^TM technology to develop a high-throughput assay to monitor ligand binding to a member of the tumor necrosis factor receptor superfamily. We expressed a fusion protein consisting of the extracellular domain of the OX40 receptor with the constant domains of human IgG. In the presence of OX40 ligand, we determined a binding affinity constant consistent with reported values and optimized the protocol to develop a simple, homogeneous, and sensitive binding assay in a 384-well format. Finally, we assessed if this system could identify small peptides capable of inhibiting the OX40 receptor and ligand interaction. The results showed that the assay was able to detect such peptides and could be used to launch a high-throughput screening campaign for small molecules able to prevent OX40 receptor activation. (Journal of Biomolecular Screening 2003:522-532)

Key Words: Alphascreen technology • protein-protein interaction • TNF receptor superfamily • high-throughput binding assay

Journal of Biomolecular Screening, Vol. 8, No. 5, 522-532 (2003)
DOI: 10.1177/1087057103257804


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Smotrov, A. Mathur, I. Kariv, C. M. Moxham, and N. Bays Development of a Cell-Based Assay for Measurement of c-Met Phosphorylation Using AlphaScreenTM Technology and High-Content Imaging Analysis J Biomol Screen, April 1, 2009; 14(4): 404 - 411. [Abstract] [PDF]

				N. Fujii, L. You, Z. Xu, K. Uematsu, J. Shan, B. He, I. Mikami, L. R. Edmondson, G. Neale, J. Zheng, et al. An Antagonist of Dishevelled Protein-Protein Interaction Suppresses {beta}-Catenin-Dependent Tumor Cell Growth Cancer Res., January 15, 2007; 67(2): 573 - 579. [Abstract] [Full Text] [PDF]

				A. Von Leoprechting, R. Kumpf, S. Menzel, D. Reulle, R. Griebel, M. J. Valler, and F. H. Buttner Miniaturization and Validation of a High-Throughput Serine Kinase Assay Using the Alpha Screen Platform J Biomol Screen, December 1, 2004; 9(8): 719 - 725. [Abstract] [PDF]